Abstract Objectives Anti-RNA polymerase III antibodies (ARA) are frequent in systemic sclerosis (SSc). However, the reported prevalence …
Abstract Objectives Anti-RNA polymerase III antibodies (ARA) are frequent in systemic sclerosis (SSc). However, the reported prevalence …
Abstract Objectives This study assessed how changes in lung function, skin fibrosis and digital ulceration (DU) burden predict …
Objective Systemic lupus erythematosus (SLE), a systemic autoimmune disease with heterogeneous severity, poses a challenge in …
Objective Antinuclear antibodies (ANA) are powerful biomarkers in systemic sclerosis (SSc). Functional antibodies (FA) might be …
Objective To assess safety of fertility treatments in women with systemic lupus erythematosus (SLE).
Design Data from the multicentre …
Introduction Systemic sclerosis (SSc) is a rare autoimmune disease currently classified into two subgroups based on skin extension. The …
Abstract Objectives The objectives of this study were to compare fatigue in a large multinational SSc cohort with general population …
A jats:scbstractjats:sc
Background Systemic sclerosis (SSc) is an autoimmune disease with high mortality with lung involvement being …
Background: Anemia is considered a risk factor of severity in systemic sclerosis. Yet, limited data are available on the frequency and …
Abstract Objectives To compare physical function in systemic sclerosis (SSc, scleroderma) to general population normative data and …
Abstract Objectives Patients with systemic sclerosis (SSc) are at increased risk for osteoporosis (OP) and associated fragility …
Background: Systemic sclerosis is a fibrotic disease. Body image assessments could be key in optimizing care; however, data are scarce. …
Objective The objectives were to (1) compare satisfaction with social roles and activities in a large multinational systemic sclerosis …
Abstract Objective The renin-angiotensin-aldosterone system (RAAS) and glucocorticoids (GCs) are involved in vascular remodeling and …
Objectives Although dyslipidemia is a strong risk factor for thrombosis in antiphospholipid syndrome (APS), it has been poorly studied. …
Abstract Objectives The specific roles of remission status, lupus low disease activity state (LLDAS), and damage accrual on the …
Objectives The Social Appearance Anxiety Scale (SAAS) is a 16-item questionnaire developed to evaluate fear of appearance-based …
Purpose of review Systemic sclerosis (SSc) is a severe rheumatic disease characterized by a considerable heterogeneity in clinical …
Abstract Background Rituximab (RTX) is widely administered to patients with autoimmune disease (AID). This study aimed to estimate the …
Abstract Objective In patients with SSc, peripheral vasculopathy can promote critical ischaemia and gangrene. The aim of this study was …
Objectives The Scleroderma Patient-centered Intervention Network (SPIN) Cohort uses the cohort multiple randomised controlled trial …
Objective Valid measures of appearance concern are needed in systemic sclerosis (SSc), a rare, disfiguring autoimmune disease. The …
Introduction The long-term risk of first thrombosis and benefit of prophylaxis in antiphospholipid antibody (aPL) carriers without …
Objective Pulmonary hypertension (PH) is a frequent and life‐limiting complication of systemic sclerosis (SSc). However, data on …